You may also be interested in...
Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis
Sotagliflozin reduces cardiovascular risk for patients with diabetes and worsening heart failure
Quality Evidence Briefings, Cardiology, Cardiovascular conditions, Diabetes and other endocrinal, nutritional and metabolic conditions, Diabetes
Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension